Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Ovarian Neoplasms

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 113 articles: HTML format

Single Articles

July 2008
1. BONOME T , Levine DA, Shih J, Randonovich M, et al
   A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
   Cancer Res. 2008;68:5478-86.
   PubMed     Related articles    Abstract available
   
   
   
2. KIKUCHI R , Tsuda H, Kozaki K, Kanai Y, et al
   Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
   Cancer Res. 2008;68:5067-75.
   PubMed     Related articles    Abstract available
   
   
   June 2008
3. ABEDINI MR , Muller EJ, Brun J, Bergeron R, et al
   Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
   Cancer Res. 2008;68:4511-7.
   PubMed     Related articles    Abstract available
   
   
   
4. ZHANG S , Balch C, Chan MW, Lai HC, et al
   Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
   Cancer Res. 2008;68:4311-20.
   PubMed     Related articles    Abstract available
   
   
   April 2008
5. BASU A , Adkins B, Basu C
   Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway.
   Cancer Res. 2008;68:2795-802.
   PubMed     Related articles    Abstract available
   
   
   
6. SWISHER EM , Sakai W, Karlan BY, Wurz K, et al
   Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.
   Cancer Res. 2008;68:2581-6.
   PubMed     Related articles    Abstract available
   
   
   
7. KELEMEN LE , Sellers TA, Schildkraut JM, Cunningham JM, et al
   Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
   Cancer Res. 2008;68:2498-506.
   PubMed     Related articles    Abstract available
   
   
   
8. SAWADA K , Mitra AK, Radjabi AR, Bhaskar V, et al
   Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
   Cancer Res. 2008;68:2329-39.
   PubMed     Related articles    Abstract available
   
   
   
9. LOTAN T , Hickson J, Souris J, Huo D, et al
   c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
   Cancer Res. 2008;68:2166-75.
   PubMed     Related articles    Abstract available
   
   
   February 2008
10. JEON BH , Jang C, Han J, Kataru RP, et al
    Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
    Cancer Res. 2008;68:1100-9.
    PubMed     Related articles    Abstract available
    
    
    
11. POTAPOVA A , Hoffman AM, Godwin AK, Al-Saleem T, et al
    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Cancer Res. 2008;68:998-1002.
    PubMed     Related articles    Abstract available
    
    
    
12. ZECCHINI S , Bianchi M, Colombo N, Fasani R, et al
    The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.
    Cancer Res. 2008;68:1110-8.
    PubMed     Related articles    Abstract available
    
    
    
13. KLINCK R , Bramard A, Inkel L, Dufresne-Martin G, et al
    Multiple alternative splicing markers for ovarian cancer.
    Cancer Res. 2008;68:657-63.
    PubMed     Related articles    Abstract available
    
    
    January 2008
14. YANG H , Kong W, He L, Zhao JJ, et al
    MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
    Cancer Res. 2008;68:425-33.
    PubMed     Related articles    Abstract available
    
    
    
15. KONG X , Wang X, Xu W, Behera S, et al
    Natriuretic peptide receptor a as a novel anticancer target.
    Cancer Res. 2008;68:249-56.
    PubMed     Related articles    Abstract available
    
    
    December 2007
16. WANG J , Zhou JY, Wu GS
    ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
    Cancer Res. 2007;67:11933-41.
    PubMed     Related articles    Abstract available
    
    
    
17. LI L , Ryser S, Dizin E, Pils D, et al
    Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Cancer Res. 2007;67:11876-85.
    PubMed     Related articles    Abstract available
    
    
    
18. GAITHER A , Porter D, Yao Y, Borawski J, et al
    A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.
    Cancer Res. 2007;67:11493-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
19. YOKOYAMA Y , Sedgewick G, Ramakrishnan S
    Endostatin Binding to Ovarian Cancer Cells Inhibits Peritoneal Attachment and Dissemination.
    Cancer Res. 2007;67:10813-10822.
    PubMed     Related articles    Abstract available
    
    
    
20. HALDER J , Lin YG, Merritt WM, Spannuth WA, et al
    Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma.
    Cancer Res. 2007;67:10976-10983.
    PubMed     Related articles    Abstract available
    
    
    
21. LANDEN CN JR , Lin YG, Armaiz Pena GN, Das PD, et al
    Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer.
    Cancer Res. 2007;67:10389-10396.
    PubMed     Related articles    Abstract available
    
    
    
22. LU L , Katsaros D, Rigault de la Longrais IA, Sochirca O, et al
    Hypermethylation of let-7a-3 in Epithelial Ovarian Cancer Is Associated with Low Insulin-like Growth Factor-II Expression and Favorable Prognosis.
    Cancer Res. 2007;67:10117-10122.
    PubMed     Related articles    Abstract available
    
    
    October 2007
23. CHANG CL , Tsai YC, He L, Wu TC, et al
    Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.
    Cancer Res. 2007;67:10047-57.
    PubMed     Related articles    Abstract available
    
    
    
24. RAVIKUMAR S , Perez-Liz G, Del Vale L, Soprano DR, et al
    Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid.
    Cancer Res. 2007;67:9266-75.
    PubMed     Related articles    Abstract available
    
    
    
25. KIM TJ , Ravoori M, Landen CN, Kamat AA, et al
    Antitumor and Antivascular Effects of AVE8062 in Ovarian Carcinoma.
    Cancer Res. 2007;67:9337-45.
    PubMed     Related articles    Abstract available
    
    
    
26. GRANOT D , Addadi Y, Kalchenko V, Harmelin A, et al
    In vivo Imaging of the Systemic Recruitment of Fibroblasts to the Angiogenic Rim of Ovarian Carcinoma Tumors.
    Cancer Res. 2007;67:9180-9.
    PubMed     Related articles    Abstract available
    
    
    September 2007
27. IORIO MV , Visone R, Di Leva G, Donati V, et al
    MicroRNA Signatures in Human Ovarian Cancer.
    Cancer Res. 2007;67:8699-8707.
    PubMed     Related articles    Abstract available
    
    
    
28. KRYCZEK I , Wei S, Zhu G, Myers L, et al
    Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma.
    Cancer Res. 2007;67:8900-5.
    PubMed     Related articles    Abstract available
    
    
    
29. STAVENHAGEN JB , Gorlatov S, Tuaillon N, Rankin CT, et al
    Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Cancer Res. 2007;67:8882-90.
    PubMed     Related articles    Abstract available
    
    
    
30. LI X , Shen L, Zhang J, Su J, et al
    Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.
    Cancer Res. 2007;67:8716-24.
    PubMed     Related articles    Abstract available
    
    
    
31. CORNEY DC , Flesken-Nikitin A, Godwin AK, Wang W, et al
    MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Cancer Res. 2007;67:8433-8.
    PubMed     Related articles    Abstract available
    
    
    
32. TSUDA N , Chang DZ, Mine T, Efferson C, et al
    Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells.
    Cancer Res. 2007;67:8378-87.
    PubMed     Related articles    Abstract available
    
    
    August 2007
33. KIKUCHI R , Tsuda H, Kanai Y, Kasamatsu T, et al
    Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer.
    Cancer Res. 2007;67:7095-7105.
    PubMed     Related articles    Abstract available
    
    
    
34. WEI S , Kryczek I, Edwards RP, Zou L, et al
    Interleukin-2 Administration Alters the CD4+FOXP3+ T-Cell Pool and Tumor Trafficking in Patients with Ovarian Carcinoma.
    Cancer Res. 2007;67:7487-94.
    PubMed     Related articles    Abstract available
    
    
    
35. LI B , Allendorf DJ, Hansen R, Marroquin J, et al
    Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.
    Cancer Res. 2007;67:7421-30.
    PubMed     Related articles    Abstract available
    
    
    
36. JACQUEMONT C , Taniguchi T
    Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
    Cancer Res. 2007;67:7395-405.
    PubMed     Related articles    Abstract available
    
    
    
37. SATPATHY M , Cao L, Pincheira R, Emerson R, et al
    Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
    Cancer Res. 2007;67:7194-202.
    PubMed     Related articles    Abstract available
    
    
    July 2007
38. ROSANO L , Di Castro V, Spinella F, Tortora G, et al
    Combined targeting of endothelin a receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity.
    Cancer Res. 2007;67:6351-9.
    PubMed     Related articles    Abstract available
    
    
    
39. VENERE M , Snyder A, Zgheib O, Halazonetis TD, et al
    Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
    Cancer Res. 2007;67:6100-5.
    PubMed     Related articles    Abstract available
    
    
    June 2007
40. ROBINSON-SMITH TM , Isaacsohn I, Mercer CA, Zhou M, et al
    Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice.
    Cancer Res. 2007;67:5708-16.
    PubMed     Related articles    Abstract available
    
    
    
41. DAIKOKU T , Tranguch S, Chakrabarty A, Wang D, et al
    Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-{delta} Signaling in Epithelial Ovarian Cancer.
    Cancer Res. 2007;67:5285-92.
    PubMed     Related articles    Abstract available
    
    
    May 2007
42. HEMPEL N , How T, Dong M, Murphy SK, et al
    Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion.
    Cancer Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. BARBER A , Zhang T, Demars LR, Conejo-Garcia J, et al
    Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer.
    Cancer Res. 2007;67:5003-8.
    PubMed     Related articles    Abstract available
    
    
    
44. CHEN Y , Clark S, Wong T, Chen Y, et al
    Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models.
    Cancer Res. 2007;67:4924-32.
    PubMed     Related articles    Abstract available
    
    
    
45. VAN VLERKEN LE , Duan Z, Seiden MV, Amiji MM, et al
    Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
    Cancer Res. 2007;67:4843-50.
    PubMed     Related articles    Abstract available
    
    
    
46. BAK SP , Walters JJ, Takeya M, Conejo-Garcia JR, et al
    Scavenger receptor-a-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.
    Cancer Res. 2007;67:4783-9.
    PubMed     Related articles    Abstract available
    
    
    
47. PETROCCA F , Calin GA, Croce CM
    ARLTS1 Trp149Stop Mutation and the Risk of Ovarian Cancer.
    Cancer Res. 2007;67:4534.
    PubMed     Related articles   
    
    
    
48. MASOJC B , Medrek K, Debniak T, Lubinski J, et al
    ARLTS1 Trp149Stop Mutation and the Risk of Ovarian Cancer.
    Cancer Res. 2007;67:4533.
    PubMed     Related articles   
    
    
    
49. DARCY KM , Tian C, Reed E
    A Gynecologic Oncology Group Study of Platinum-DNA Adducts and Excision Repair Cross-Complementation Group 1 Expression in Optimal, Stage III Epithelial Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.
    Cancer Res. 2007;67:4474-81.
    PubMed     Related articles    Abstract available
    
    
    April 2007
50. SCHUMACHER JJ , Dings RP, Cosin J, Subramanian IV, et al
    Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
    Cancer Res. 2007;67:3683-90.
    PubMed     Related articles    Abstract available
    
    
    
51. MALONEY A , Clarke PA, Naaby-Hansen S, Stein R, et al
    Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Cancer Res. 2007;67:3239-53.
    PubMed     Related articles    Abstract available
    
    
    
52. NANJUNDAN M , Nakayama Y, Cheng KW, Lahad J, et al
    Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer.
    Cancer Res. 2007;67:3074-84.
    PubMed     Related articles    Abstract available
    
    
    
53. GAYTHER SA , Song H, Ramus SJ, Kjaer SK, et al
    Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
    Cancer Res. 2007;67:3027-35.
    PubMed     Related articles    Abstract available
    
    
    
54. ZHOU W , Han WF, Landree LE, Thupari JN, et al
    Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells.
    Cancer Res. 2007;67:2964-71.
    PubMed     Related articles    Abstract available
    
    
    
55. BEHBAKHT K , Qamar L, Aldridge CS, Coletta RD, et al
    Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.
    Cancer Res. 2007;67:3036-42.
    PubMed     Related articles    Abstract available
    
    
    March 2007
56. SWISHER EM , King MC
    Defining women at high risk of ovarian cancer.
    Cancer Res. 2007;67:2902.
    PubMed     Related articles   
    
    
    
57. BAGBY GC , Pejovic T
    Defining women at high risk of ovarian cancer.
    Cancer Res. 2007;67:2902-3.
    PubMed     Related articles   
    
    
    
58. MABUCHI S , Altomare DA, Connolly DC, Klein-Szanto A, et al
    RAD001 (Everolimus) Delays Tumor Onset and Progression in a Transgenic Mouse Model of Ovarian Cancer.
    Cancer Res. 2007;67:2408-13.
    PubMed     Related articles    Abstract available
    
    
    
59. HAMA Y , Urano Y, Koyama Y, Kamiya M, et al
    A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate.
    Cancer Res. 2007;67:2791-9.
    PubMed     Related articles    Abstract available
    
    
    
60. TOLMACHEV V , Orlova A, Pehrson R, Galli J, et al
    Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
    Cancer Res. 2007;67:2773-82.
    PubMed     Related articles    Abstract available
    
    
    
61. JACOBS S , Thompson ER, Nannya Y, Yamamoto G, et al
    Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays.
    Cancer Res. 2007;67:2544-51.
    PubMed     Related articles    Abstract available
    
    
    
62. ORLOVA A , Tolmachev V, Pehrson R, Lindborg M, et al
    Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.
    Cancer Res. 2007;67:2178-86.
    PubMed     Related articles    Abstract available
    
    
    
63. SYMOWICZ J , Adley BP, Gleason KJ, Johnson JJ, et al
    Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
    Cancer Res. 2007;67:2030-9.
    PubMed     Related articles    Abstract available
    
    
    
64. MORENO-BUENO G , Fernandez-Marcos PJ, Collado M, Tendero MJ, et al
    Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
    Cancer Res. 2007;67:1927-34.
    PubMed     Related articles    Abstract available
    
    
    February 2007
65. ALBANITO L , Madeo A, Lappano R, Vivacqua A, et al
    G Protein-Coupled Receptor 30 (GPR30) Mediates Gene Expression Changes and Growth Response to 17{beta}-Estradiol and Selective GPR30 Ligand G-1 in Ovarian Cancer Cells.
    Cancer Res. 2007;67:1859-1866.
    PubMed     Related articles    Abstract available
    
    
    
66. FISTER S , Gunthert AR, Emons G, Grundker C, et al
    Gonadotropin-Releasing Hormone Type II Antagonists Induce Apoptotic Cell Death in Human Endometrial and Ovarian Cancer Cells In vitro and In vivo.
    Cancer Res. 2007;67:1750-6.
    PubMed     Related articles    Abstract available
    
    
    
67. SAWADA K , Radjabi AR, Shinomiya N, Kistner E, et al
    c-Met Overexpression Is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and Invasion.
    Cancer Res. 2007;67:1670-9.
    PubMed     Related articles    Abstract available
    
    
    
68. HANSEN JE , Fischer LK, Chan G, Chang SS, et al
    Antibody-mediated p53 protein therapy prevents liver metastasis in vivo.
    Cancer Res. 2007;67:1769-74.
    PubMed     Related articles    Abstract available
    
    
    
69. LU C , Bonome T, Li Y, Kamat AA, et al
    Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.
    Cancer Res. 2007;67:1757-68.
    PubMed     Related articles    Abstract available
    
    
    
70. CARLSTEN M , Bjorkstrom NK, Norell H, Bryceson Y, et al
    DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
    Cancer Res. 2007;67:1317-25.
    PubMed     Related articles    Abstract available
    
    
    January 2007
71. KULBE H , Thompson R, Wilson JL, Robinson S, et al
    The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.
    Cancer Res. 2007;67:585-92.
    PubMed     Related articles    Abstract available
    
    
    
72. SINGH AP , Chaturvedi P, Batra SK
    Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
    Cancer Res. 2007;67:433-6.
    PubMed     Related articles    Abstract available
    
    
    
73. KAMAT AA , Kim TJ, Landen CN Jr, Lu C, et al
    Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer.
    Cancer Res. 2007;67:281-8.
    PubMed     Related articles    Abstract available
    
    
    
74. PERSSON M , Gedda L, Lundqvist H, Tolmachev V, et al
    [177Lu]pertuzumab: experimental therapy of HER-2-expressing xenografts.
    Cancer Res. 2007;67:326-31.
    PubMed     Related articles    Abstract available
    
    
    December 2006
75. CRISTIANO BE , Chan JC, Hannan KM, Lundie NA, et al
    A Specific Role for AKT3 in the Genesis of Ovarian Cancer through Modulation of G2-M Phase Transition.
    Cancer Res. 2006;66:11718-25.
    PubMed     Related articles    Abstract available
    
    
    November 2006
76. CHEUNG LW , Leung PC, Wong AS
    Gonadotropin-Releasing Hormone Promotes Ovarian Cancer Cell Invasiveness through c-Jun NH2-Terminal Kinase-Mediated Activation of Matrix Metalloproteinase (MMP)-2 and MMP-9.
    Cancer Res. 2006;66:10902-10910.
    PubMed     Related articles    Abstract available
    
    
    
77. HOLZER AK , Howell SB
    The internalization and degradation of human copper transporter 1 following cisplatin exposure.
    Cancer Res. 2006;66:10944-52.
    PubMed     Related articles    Abstract available
    
    
    
78. DENKERT C , Budczies J, Kind T, Weichert W, et al
    Mass Spectrometry-Based Metabolic Profiling Reveals Different Metabolite Patterns in Invasive Ovarian Carcinomas and Ovarian Borderline Tumors.
    Cancer Res. 2006;66:10795-10804.
    PubMed     Related articles    Abstract available
    
    
    
79. CASTELLANO G , Reid JF, Alberti P, Carcangiu ML, et al
    New Potential Ligand-Receptor Signaling Loops in Ovarian Cancer Identified in Multiple Gene Expression Studies.
    Cancer Res. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
80. PETROCCA F , Iliopoulos D, Qin HR, Nicoloso MS, et al
    Alterations of the Tumor Suppressor Gene ARLTS1 in Ovarian Cancer.
    Cancer Res. 2006;66:10287-91.
    PubMed     Related articles    Abstract available
    
    
    October 2006
81. SONG H , Ramus SJ, Shadforth D, Quaye L, et al
    Common Variants in RB1 Gene and Risk of Invasive Ovarian Cancer.
    Cancer Res. 2006;66:10220-6.
    PubMed     Related articles    Abstract available
    
    
    
82. PASTORINO F , Brignole C, Di Paolo D, Nico B, et al
    Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
    Cancer Res. 2006;66:10073-82.
    PubMed     Related articles    Abstract available
    
    
    September 2006
83. PEJOVIC T , Yates JE, Liu HY, Hays LE, et al
    Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer.
    Cancer Res. 2006;66:9017-25.
    PubMed     Related articles    Abstract available
    
    
    
84. LEYTON J , Lockley M, Aerts JL, Baird SK, et al
    Quantifying the activity of adenoviral E1A CR2 deletion mutants using renilla luciferase bioluminescence and 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography imaging.
    Cancer Res. 2006;66:9178-85.
    PubMed     Related articles    Abstract available
    
    
    
85. BLASI MF , Ventura I, Aquilina G, Degan P, et al
    A human cell-based assay to evaluate the effects of alterations in the MLH1 mismatch repair gene.
    Cancer Res. 2006;66:9036-44.
    PubMed     Related articles    Abstract available
    
    
    
86. XING D , Orsulic S
    A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
    Cancer Res. 2006;66:8949-53.
    PubMed     Related articles    Abstract available
    
    
    
87. SUNDE JS , Donninger H, Wu K, Johnson ME, et al
    Expression Profiling Identifies Altered Expression of Genes That Contribute to the Inhibition of Transforming Growth Factor-{beta} Signaling in Ovarian Cancer.
    Cancer Res. 2006;66:8404-12.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    August 2006
88. KIM KS , Sengupta S, Berk M, Kwak YG, et al
    Hypoxia Enhances Lysophosphatidic Acid Responsiveness in Ovarian Cancer Cells and Lysophosphatidic Acid Induces Ovarian Tumor Metastasis In vivo.
    Cancer Res. 2006;66:7983-90.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    July 2006
89. YANG R , Cai Z, Zhang Y, Yutzy WH 4th, et al
    CD80 in Immune Suppression by Mouse Ovarian Carcinoma-Associated Gr-1+CD11b+ Myeloid Cells.
    Cancer Res. 2006;66:6807-15.
    PubMed     Related articles    Abstract available
    
    
    June 2006
90. PARK JT , Li M, Nakayama K, Mao TL, et al
    Notch3 gene amplification in ovarian cancer.
    Cancer Res. 2006;66:6312-8.
    PubMed     Related articles    Abstract available
    
    
    
91. NORELL H , Carlsten M, Ohlum T, Malmberg KJ, et al
    Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity.
    Cancer Res. 2006;66:6387-94.
    PubMed     Related articles    Abstract available
    
    
    
92. NARITA K , Staub J, Chien J, Meyer K, et al
    HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Cancer Res. 2006;66:6025-32.
    PubMed     Related articles    Abstract available
    
    
    
93. ABBOSH PH , Montgomery JS, Starkey JA, Novotny M, et al
    Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Cancer Res. 2006;66:5582-91.
    PubMed     Related articles    Abstract available
    
    
    May 2006
94. GRITZAPIS AD , Mahaira LG, Perez SA, Cacoullos NT, et al
    Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo.
    Cancer Res. 2006;66:5452-60.
    PubMed     Related articles    Abstract available
    
    
    
95. NAKANISHI T , Bailey-Dell KJ, Hassel BA, Shiozawa K, et al
    Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
    Cancer Res. 2006;66:5007-11.
    PubMed     Related articles    Abstract available
    
    
    
96. LUDWIG JA , Szakacs G, Martin SE, Chu BF, et al
    Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
    Cancer Res. 2006;66:4808-15.
    PubMed     Related articles    Abstract available
    
    
    
97. ZHANG L , Huang J, Yang N, Liang S, et al
    Integrative Genomic Analysis of Protein Kinase C (PKC) Family Identifies PKC{iota} as a Biomarker and Potential Oncogene in Ovarian Carcinoma.
    Cancer Res. 2006;66:4627-4635.
    PubMed     Related articles    Abstract available
    
    
    April 2006
98. SUBRAMANIAN IV , Bui Nguyen TM, Truskinovsky AM, Tolar J, et al
    Adeno-Associated Virus-Mediated Delivery of a Mutant Endostatin in Combination with Carboplatin Treatment Inhibits Orthotopic Growth of Ovarian Cancer and Improves Long-term Survival.
    Cancer Res. 2006;66:4319-28.
    PubMed     Related articles    Abstract available
    
    
    
99. ORLOVA A , Magnusson M, Eriksson TL, Nilsson M, et al
    Tumor imaging using a picomolar affinity HER2 binding affibody molecule.
    Cancer Res. 2006;66:4339-48.
    PubMed     Related articles    Abstract available
    
    
    
100. CHOI JH , Choi KC, Auersperg N, Leung PC, et al
     Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.
     Cancer Res. 2006;66:3912-20.
     PubMed     Related articles    Abstract available
     
     
     
101. KELLY MG , Alvero AB, Chen R, Silasi DA, et al
     TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.
     Cancer Res. 2006;66:3859-68.
     PubMed     Related articles    Abstract available
     
     
     
102. BAZZARO M , Lee MK, Zoso A, Stirling WL, et al
     Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis.
     Cancer Res. 2006;66:3754-63.
     PubMed     Related articles    Abstract available
     
     
     
103. SPOELSTRA NS , Manning NG, Higashi Y, Darling D, et al
     The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers.
     Cancer Res. 2006;66:3893-902.
     PubMed     Related articles    Abstract available
     
     
     
104. MACOR P , Mezzanzanica D, Cossetti C, Alberti P, et al
     Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
     Cancer Res. 2006;66:3876-83.
     PubMed     Related articles    Abstract available
     
     
     
105. XUAN JA , Schneider D, Toy P, Lin R, et al
     Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture.
     Cancer Res. 2006;66:3611-9.
     PubMed     Related articles    Abstract available
     
     
     
106. VILGELM A , Lian Z, Wang H, Beauparlant SL, et al
     Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice.
     Cancer Res. 2006;66:3375-80.
     PubMed     Related articles    Abstract available
     
     
     March 2006
107. VILLANI MG , Appierto V, Cavadini E, Bettiga A, et al
     4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
     Cancer Res. 2006;66:3238-47.
     PubMed     Related articles    Abstract available
     
     
     
108. BALKWILL FR , Ashworth A, Bast RC, Berek JS, et al
     10th Biennial Helene Harris Memorial Trust meeting.
     Cancer Res. 2006;66:2904-6.
     PubMed     Related articles    Abstract available
     
     
     February 2006
109. HICKSON JA , Huo D, Vander Griend DJ, Lin A, et al
     The p38 Kinases MKK4 and MKK6 Suppress Metastatic Colonization in Human Ovarian Carcinoma.
     Cancer Res. 2006;66:2264-70.
     PubMed     Related articles    Abstract available
     
     
     
110. BOERBOOM D , White LD, Dalle S, Courty J, et al
     Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
     Cancer Res. 2006;66:1964-73.
     PubMed     Related articles    Abstract available
     
     
     
111. ERKANLI A , Taylor DD, Dean D, Eksir F, et al
     Application of Bayesian Modeling of Autologous Antibody Responses against Ovarian Tumor-Associated Antigens to Cancer Detection.
     Cancer Res. 2006;66:1792-8.
     PubMed     Related articles    Abstract available
     
     
     
112. BILSLAND AE , Stevenson K, Atkinson S, Kolch W, et al
     Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.
     Cancer Res. 2006;66:1363-70.
     PubMed     Related articles    Abstract available
     
     
     
113. HENDRIX ND , Wu R, Kuick R, Schwartz DR, et al
     Fibroblast growth factor 9 has oncogenic activity and is a downstream target of wnt signaling in ovarian endometrioid adenocarcinomas.
     Cancer Res. 2006;66:1354-62.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: